A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

NCT00441558 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1723

Enrollment

INDUSTRY

Sponsor class

Stopped terminated for administrative reasons

Conditions

Sexual Dysfunctions, Psychological

Interventions

DRUG: Flibanserin

Sponsor

Sprout Pharmaceuticals, Inc